Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-22

Clinical Trial Update: Evaluate the Efficacy of Using Modified Qing-Ying Decoction in Atopic Dermatitis Children [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating modified Qing-Ying Decoction for atopic dermatitis in children; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Modified Qing-Ying Decoction

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Atopic Dermatitis | Phase 2, Phase 3 | Status: UNKNOWN